Denmark · Delayed Price · Currency is DKK SP Group Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw record revenue and profit growth, driven by strong organic performance and the Idé-Pro acquisition. Margins remained robust, guidance for 2026 is maintained despite geopolitical risks, and capital allocation includes dividends and a new share buyback.
Fiscal Year 2025
-
Record Q4 drove modest full-year growth, with strong subcontracting offsetting own product declines. 2026 guidance is ambitious, fueled by the Idé-Pro acquisition and new customer agreements, but risks remain from geopolitical and raw material uncertainties.
-
The acquisition brings advanced prototyping, in-house tool production, and new material capabilities, with expected annual synergies of DKK 20–25 million and significant revenue and EBITDA growth by 2026. Integration leverages existing teams, and immediate cross-selling is underway.
-
Q3 2025 saw a 3.3% sales decline due to postponed orders and weaker own product sales, but sub-supplier business grew and the order book for Q4 is strong. Full-year guidance is maintained, with major investments in healthcare capacity and a leadership transition planned.
-
Record Q1 was followed by a Q2 slowdown, with H1 revenue down 1.2% and margins pressured by postponed orders and lower own product sales. Full-year guidance was revised to flat revenue, with continued investment in medical capacity and increased share buybacks.
-
Q1 2025 delivered record revenue and profit, led by strong healthcare growth and robust own brand sales. Investments focused on medical production capacity, while tariff and geopolitical uncertainties remain a risk. Net debt to EBITDA reached a low of 1.3.
Fiscal Year 2024
-
Record 2024 results with 12% revenue growth and strong margin expansion driven by own products. 2025 guidance is more cautious, targeting 3%-10% growth amid industrial uncertainty, with continued focus on organic growth, acquisitions, and sustainability.
-
H1 2024 saw robust revenue and profit growth, driven by proprietary products and international sales, with upgraded full-year guidance and a new U.S. factory completed. Sustainability initiatives advanced, and a share buyback program was launched.